Translational Research in Cancer
Translational Research in Cancer
批准号:
8738098
负责人:
RICHARD G PESTELL
金额:
$7.32万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-18 至 2018-05-31
关键词:
AntigensApoptosisAreaBasic ScienceBiochemistryBloodBreastBreast Cancer Early DetectionCancer BiologyCancer CenterCancer Center Support GrantCancer Immunology ScienceCancer PatientCellular biologyChromosomal InstabilityClinicalClinical ResearchClinical SciencesCollaborationsCollectionColon CarcinomaCoordination and CollaborationDNA RepairDataDevelopmentDiagnosisDisciplineDoctor of PhilosophyEnvironmentEquipmentFacility DesignsFacultyFundingGeneticGenomics Shared ResourceGrantGrowth FactorHumanHuman PathologyImageInstitutesInstitutionInvestigationJournalsLeadershipMalignant NeoplasmsMedical OncologyMethodologyMissionModalityMolecularMonitorNeoplasm MetastasisPathway interactionsPeer ReviewPhysiciansPreventionProductivityProgram Research Project GrantsProteomicsPublicationsQuality of lifeRadiationRadiation Induced DNA DamageReagentRecruitment ActivityResearchResearch ActivityResearch PersonnelResearch SupportResource SharingScientistSeriesSignal TransductionSignal Transduction PathwayStrategic PlanningStressTrainingTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesUniversity HospitalsVaccinationangiogenesisanticancer researchauthoritybasecancer carecancer geneticscancer genomicshuman tissuemalignant breast neoplasmmeetingsmembermultimodality cancer therapynovelnovel strategiesoncologypreventprogramssquare foottherapeutic targettumor
中文摘要
这项关于癌症中心支持赠款(CCSG)的提案要求提供资金,以支持基梅尔癌症中心(KCC)的癌症研究活动,以通过将基础研究发现转化为预防、诊断、监测和治疗人类癌症的新策略来提高癌症患者的存活率和生活质量。坎摩尔癌症中心的主要任务是发现癌症遗传学、细胞生物学、生物化学和免疫学的最新发现,并将其转化为治疗癌症的新方法。
坎摩尔癌症中心由6个项目和13个共享资源组成,以支持这些研究项目。每个项目的研究人员都参与了方案内和方案间的合作,并在为这些合作研究获得同行评议的资金方面取得了极其成功的成果。KCC内的环境促进了许多合作研究和出版物,这些研究和出版物为癌症研究的重要进展做出了贡献。
KCC项目得到了7830万美元赞助资金的支持。资金来自NCI赞助的73个项目,包括2个NCI项目间项目赠款,总额为3440万美元。主任及其招募人员的努力增加了对慈善大学和医院的支持。托马斯·杰斐逊大学癌症研究和护理的重要性体现在该研究所主任对临床和研究活动的权力上,该研究所的面积为144,208平方英尺。英国《金融时报》,以及新设施的建设(232,114平方米包括新的乳房中心、肿瘤学中心和研究空间。这些新设施将容纳KCC调查人员的基本、临床和翻译工作。这些新的KCC设施将进一步加强基梅尔癌症中心的翻译癌症研究工作。
英文摘要
This proposal for a Cancer Center Support Grant (CCSG) requests funding to support the cancer research activities of the Kimmel Cancer Center (KCC), in order to increase the survival and quality of life of cancer patients by translating basic research discoveries into new strategies to prevent, diagnose, monitor and cure human cancer. The major thrust of the Kimmel Cancer Center is in discovery and translation of the latest findings in the genetics, cell biology, biochemistry and immunology of cancer into novel modalities to cure cancer.
The Kimmel Cancer Center consists of six programs and thirteen shared resources to support the research programs. Investigators in each program are involved in intra-programmatic and interprogrammatic collaborations and have been extremely successful in obtaining peer-reviewed funding for these collaborative studies. The environment within the KCC has facilitated numerous collaborative studies and publications that have contributed to im portant advances in cancer research.
The KCC programs are supported by $78.3M in total sponsored funding. Funding comes from 73 NCI sponsored projects, including 2 inter-programmatic NCI program project grants, and totals $34.4M. The efforts of the Director and his recruits have resulted in increased philanthropic University and Hospital support. The importance of cancer research and care at Thomas Jefferson University is reflected in the Director's authority over clinical and research activities at the Institution, encompassing 144,208 sq. ft, and the construction of new facilities (232,114 sq. ft) including the new Breast Center, Oncology Center and research space. These new facilities will accommodate the basic, clinical and translational efforts of the KCC investigators. These new KCC facilities will enhance even further the translational cancer research effort of the Kimmel Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
-
批准号:10057534
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2020
-
负责人:RICHARD G PESTELL
-
依托单位:
Molecular Biology and Genetics Program
-
批准号:8753662
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2014
-
负责人:RICHARD G PESTELL
-
依托单位:
Developmental Funds
-
批准号:8302938
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2011
-
负责人:RICHARD G PESTELL
-
依托单位:
Radiation Research and Therapeutics
-
批准号:8302934
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2011
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934783
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:8193135
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:7653332
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
-
批准号:9446542
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:7896701
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
-
批准号:8697542
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:8291884
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934787
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934802
-
项目类别:
-
资助金额:$95.69万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Cancer Center Administration
-
批准号:7712899
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Gastro Intestinal Cancer
-
批准号:7712909
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Developmental Funds
-
批准号:7712895
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Cell Biology and Signaling
-
批准号:7712901
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Transgenic Knockout Mice
-
批准号:7712920
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Protocol Review and Monitoring System (PRMS)
-
批准号:7712938
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Data Safety Monitoring Board (DSMB)
-
批准号:7712941
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: